TNF Pharmaceuticals Statistics
Total Valuation
TNFA has a market cap or net worth of $3.18 million. The enterprise value is -$9.51 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, before market open.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TNFA has 2.37 million shares outstanding. The number of shares has increased by 44.02% in one year.
| Current Share Class | 2.37M |
| Shares Outstanding | 2.37M |
| Shares Change (YoY) | +44.02% |
| Shares Change (QoQ) | +6.28% |
| Owned by Insiders (%) | 8.36% |
| Owned by Institutions (%) | 2.90% |
| Float | 2.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.48 |
| Quick Ratio | 2.26 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -297.63% and return on invested capital (ROIC) is -139.31%.
| Return on Equity (ROE) | -297.63% |
| Return on Assets (ROA) | -32.43% |
| Return on Capital (ROIC) | -139.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.89M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.46% in the last 52 weeks. The beta is 2.67, so TNFA's price volatility has been higher than the market average.
| Beta (5Y) | 2.67 |
| 52-Week Price Change | -88.46% |
| 50-Day Moving Average | 1.55 |
| 200-Day Moving Average | 2.33 |
| Relative Strength Index (RSI) | 40.66 |
| Average Volume (20 Days) | 27,986 |
Short Selling Information
The latest short interest is 252,883, so 10.67% of the outstanding shares have been sold short.
| Short Interest | 252,883 |
| Short Previous Month | 243,632 |
| Short % of Shares Out | 10.67% |
| Short % of Float | 11.66% |
| Short Ratio (days to cover) | 4.97 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.40M |
| Pretax Income | -12.29M |
| Net Income | -23.35M |
| EBITDA | n/a |
| EBIT | -13.40M |
| Earnings Per Share (EPS) | -$11.94 |
Full Income StatementBalance Sheet
The company has $13.07 million in cash and $25,803 in debt, giving a net cash position of $13.04 million or $5.50 per share.
| Cash & Cash Equivalents | 13.07M |
| Total Debt | 25,803 |
| Net Cash | 13.04M |
| Net Cash Per Share | $5.50 |
| Equity (Book Value) | 382,293 |
| Book Value Per Share | -0.02 |
| Working Capital | 8.57M |
Full Balance SheetCash Flow
| Operating Cash Flow | -9.67M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.67M |
| FCF Per Share | -$4.08 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |